Aspirin, clopidogrel and prasugrel monotherapy in patients with type 2 diabetes mellitus: a double-blind randomised controlled trial of the effects on thrombotic markers and microRNA levels

BACKGROUND: Despite increased atherothrombotic risk in type 2 diabetes mellitus, (T2DM) the best preventative antithrombotic strategy remains undetermined. We defined the effects of three antiplatelet agents on functional readout and biomarker kinetics in platelet activation and coagulation in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Parker, William A. E., Schulte, Christian, Barwari, Temo, Phoenix, Fladia, Pearson, Sam M., Mayr, Manuel, Grant, Peter J., Storey, Robert F., Ajjan, Ramzi A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945631/
https://www.ncbi.nlm.nih.gov/pubmed/31910903
http://dx.doi.org/10.1186/s12933-019-0981-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945631/
https://www.ncbi.nlm.nih.gov/pubmed/31910903
http://dx.doi.org/10.1186/s12933-019-0981-3

Ejemplares similares